Retinoblastoma: Lessons and challenges from developing countries. Ellsworth Lecture 2011

Ophthalmic Genetics

Volumn 32, Issue 4, 2011, Pages 196-203

  Chantada, Guillermo L ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

retinoblastoma early diagnosis; retinoblastoma treatment

Indexed keywords

CANCER PATIENT; CANCER SURVIVAL; DELAYED DIAGNOSIS; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; HUMAN; ORGAN PRESERVATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; SOCIOECONOMICS; TREATMENT OUTCOME;

DEVELOPING COUNTRIES; EARLY DIAGNOSIS; HUMANS; RETINAL NEOPLASMS; RETINOBLASTOMA; SURVIVAL RATE;

EID: 80054870873     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2011.592173     Document Type: Review

References (56)

1. Abramson DH, Ellsworth RM, Grumbach N, Kitchin FD. Retinoblastoma: survival, age at detection and comparison 1914-1958, 1958-1983 J Pediatr Ophthalmol Strabismus 1985;22(6):246-250 (Pubitemid 16203837)
2. Moll AC, Kuik DJ, Bouter LM, et al . Incidence and survival of retinoblastoma in The Netherlands: a register based study 1862-1995. Br J Ophthalmol 1997;81(7):559-562 (Pubitemid 27354930)
3. Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, Moll AC. Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer 2009;45(18):3245-53
4. Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst 2008;100(24):1771-1779
5. Lumbroso-Le Rouic L, Aerts I, Levy-Gabriel C, et al. Conservative treatments of intraocular retinoblastoma. Ophthalmology 2008;115(8):1405-1410, 10 e1-2
6. Shields CL, Meadows AT, Leahey AM, Shields JA. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina 2004;24(6):849-862 (Pubitemid 39657480)
7. Laurie NA, Schin-Shih C, Dyer MA. Targeting MDM2 and MDMX in retinoblastoma. Curr Cancer Drug Targets 2007;7(7):689-695. (Pubitemid 350074972)
8. Pontes de Carvalho RA, Krausse ML, Murphree AL, Schmitt EE, Campochiaro PA, Maumenee IH. Delivery from episcleral exoplants. Invest Ophthalmol Vis Sci 2006;47(10):4532-4539 (Pubitemid 46579382)
9. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 2008;115(8):1398-404, 404 e1
10. Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 2009;93(9):1129-1131
11. Gallie BL, Zhao J, Vandezande K, White A, Chan HS. Global issues and opportunities for optimized retinoblastoma care. Pediatr Blood Cancer 2007;49(7Suppl.):1083-1090 (Pubitemid 350035128)
12. Leal-Leal CA, Rivera-Luna R, Flores-Rojo M, Juarez- Echenique JC, Ordaz JC, Amador-Zarco J. Survival in extraorbital metastatic retinoblastoma:treatment results. Clin Transl Oncol 2006;8(1):39-44
13. Saha V, Love S, Eden T, Micallef-Eynaud P, MacKinlay G. Determinants of symptom interval in childhood cancer. Arch Dis Child 1993;68(6):771-774 (Pubitemid 23199865)
14. Erwenne CM, Franco EL. Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic Paediatr Genet 1989;10(3):179-184 (Pubitemid 19229998)
15. Tsubono Y, Hisamichi S. A halt to neuroblastoma screening in Japan. N Engl J Med 2004;350(19):2010-2011
16. Chantada G, Fandino A, Manzitti J, Urrutia L, Schvartzman E. Late diagnosis of retinoblastoma in a developing country. Arch Dis Child 1999;80(2):171-174 (Pubitemid 29119732)
17. Wallach M, Balmer A, Munier F, et al . Shorter time to diagnosis and improved stage at presentation in Swiss patients with retinoblastoma treated from 1963 to 2004 Pediatrics 2006;118(5):e1493-1498 (Pubitemid 46393653)
18. Chantada GL, Dunkel IJ, Qaddoumi I, et al . Familial retinoblastoma in developing countries. Pediatr Blood Cancer 2009;53(3):338-342
19. Abramson DH, Beaverson K, Sangani P, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics 2003;112(6 Pt 1):1248-1255. (Pubitemid 37523403)
20. Rodriguez-Galindo C, Wilson MW, Chantada G, et al . Retinoblastoma: one world, one vision. Pediatrics 2008;122(3): e763-770
21. Leander C, Fu LC, Pena A, et al . Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 2007;49(6):817-819 (Pubitemid 47519519)
22. Leal-Leal C, Flores-Rojo M, Medina-Sanson A, et al . A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol 2004;88(8):1074-1077 (Pubitemid 39013153)
23. Canturk S, Qaddoumi I, Khetan V, et al. Survival of retinoblastoma in less-developed countries: impact of socioeconomic and health-related indicators. Br J Ophthalmol 2010;94(11):1432-1436
24. Ribeiro RC, Steliarova-Foucher E, Magrath I, et al . Baseline status of paediatric oncology care in ten low-income or midincome countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008;9(8):721-729 (Pubitemid 352038313)
25. Ribeiro KB, Lopes LF, de Camargo B. Trends in childhood leukemia mortality in Brazil and correlation with social inequalities. Cancer 2007;110(8):1823-1831 (Pubitemid 47557308)
26. Antillon F, Baez FL, Barr R, et al . AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central America. Pediatr Blood Cancer 2005;45(2):107-110 (Pubitemid 40993574)
27. Frenk J, Gonzalez-Pier E, Gomez-Dantes O, Lezana MA, Knaul FM. Comprehensive reform to improve health system performance in Mexico. Lancet 2006;368(9546):1524-1534 (Pubitemid 44634673)
28. Macinko J, Marinho de Souza Mde F, Guanais FC, da Silva Simoes CC. Going to scale with community-based primary care: an analysis of the family health program and infant mortality in Brazil, 1999-2004 Soc Sci Med 2007;65(10):2070-2080 (Pubitemid 47588578)
29. Ribeiro Kde C, Antoneli CB. Trends in eye cancer mortality among children in Brazil, 1980-2002 Pediatr Blood Cancer 2007;48(3):296-305. (Pubitemid 46238520)
30. de Cassia Braga Ribeiro K, de Camargo B. Trends in childhood renal cancer mortality in Brazil, 1980-2000 Paediatr Perinat Epidemiol 2006;20(4):323-328 (Pubitemid 43882165)
31. Costa Mda C, Mota EL, Paim JS, da Silva LM, Teixeira Mda G, Mendes CM. [Infant mortality in Brazil during recent periods of economic crisis]. Rev Saude Publica 2003;37(6):699-706 (Pubitemid 38088155)
32. Zelter M, Damel A, Gonzalez G, Schwartz L. A prospective study on the treatment of retinoblastoma in 72 patients. Cancer 1991;68(8):1685-1690
33. Chantada GL, Fandino AC, Guitter MR, et al. Results of a prospective study for the treatment of unilateral retinoblastoma. Pediatr Blood Cancer 2010;55(1):60-66
34. Gunduz K, Muftuoglu O, Gunalp I, Unal E, Tacyildiz N. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology 2006;113(9):1558-1566 (Pubitemid 44292302)
35. Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival. Br J Ophthalmol 2009;93(1):28-32
36. Sitorus RS, Moll AC, Suhardjono S, et al . The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common. Ophthalmic Genet 2009;30(1):31-36
37. Bakhshi S, Gupta S, Gogia V, Ravindranath Y. Compliance in retinoblastoma. Indian J Pediatr 2010;77(5):535-540
38. Chantada GL, Qaddoumi I, Canturk S, et al. Strategies to manage retinoblastoma in developing countries. Pediatr Blood Cancer 2010;56(3):341-8
39. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 2004;9(2):69-73 (Pubitemid 38619319)
40. Mostert S, Staresmi MN, Gundy CM, Veerman AJ. Attitude of health-care providers toward childhood leukemia patients with different socio-economic status. Pediatr Blood Cancer 2008;50(5):1001-1005. (Pubitemid 351500178)
41. Bonilla M, Rossell N, Salaverria C, et al . Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. Int J Cancer 2009;125(9):2144-2146
42. Wilimas JA, Wilson MW, Haik BG, et al . Development of retinoblastoma programs in Central America. Pediatr Blood Cancer 2009;53(1):42-46
43. Al-Obaid JA, Al-Megbel Y. Factors influencing retinoblastoma patients/siblings compliance with clinic appointments. Saudi Med J 2006;27(10):1561-1566 (Pubitemid 351833170)
44. Qaddoumi I, Nawaiseh I, Mehyar M, et al . Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in Jordan. Pediatr Blood Cancer 2008;51(2):241-244 (Pubitemid 351874419)
45. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology 1989;96(2):217-222 (Pubitemid 19049464)
46. MacKay CJ, Abramson DH, Ellsworth RM. Metastatic patterns of retinoblastoma. Arch Ophthalmol 1984;102(3):391-396 (Pubitemid 14197287)
47. Chantada G, Fandino A, Davila MT, et al . Results of a prospective study for the treatment of retinoblastoma. Cancer 2004;100(4):834-842 (Pubitemid 38176864)
48. Antoneli CB, Steinhorst F, de Cassia Braga Ribeiro K, et al . Extraocular retinoblastoma: a 13-year experience. Cancer 2003;98(6):1292-1298 (Pubitemid 37099915)
49. Chantada GL, Doz F, Orjuela M, et al . World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer 2008;50(3):692-694 (Pubitemid 351155863)
50. Chantada G, Doz F, Antoneli CB, et al . A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 2006;47(6):801-805. (Pubitemid 44476757)
51. Sastre X, Chantada GL, Doz F, et al . Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med 2009;133(8):1199-1202
52. Meadows AC, M. Dunkel, IJ, Friedman, D, Stoner, JA, Villablanca JG. Children's Oncology Group trials for retinoblastoma. In: Singh A, Damato B, Pe'er J, Murphree AL, Perry JD, eds. Essentials of Ophthalmic Oncology. Thorofare: SLACK Incorporated; 2009;204-205.
53. Menon BS, Juraida E, Alagaratnam J, et al . Chemoreduction for intraocular retinoblastoma in Malaysia. J Pediatr Hematol Oncol 2007;29(1):2-4 (Pubitemid 46143018)
54. Carcaboso AM, Chiappetta DA, Opezzo JA, et al. Episcleral implants for topotecan delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci 2010;51(4):2126-2134
55. Orellana ME, Fernandes BF, Arean C, Pifano I, Al-Kandari A, Burnier MN, Jr. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country. J Pediatr Ophthalmol Strabismus 2009;46(5):294-299
56. Schvartzman E, Chantada G, Fandino A, de Davila MT, Raslawski E, Manzitti J. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol 1996;14(5):1532-1536 (Pubitemid 26134210)